Clinical Trial Update: Dose Finding Posterolateral Thoracotomy Study [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial for postoperative pain management after posterolateral thoracotomy, sponsored by Pacira, was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain | Phase 2 | Status: TERMINATED | Results posted: 2012-05-15